Literature DB >> 22917748

Atrial remodeling in varying clinical substrates within beating human hearts: relevance to atrial fibrillation.

Saurabh Kumar1, Andrew W Teh, Caroline Medi, Peter M Kistler, Joseph B Morton, Jonathan M Kalman.   

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in human beating hearts. AF initiates self-perpetuating changes in electrophysiology, structure and functional properties of the atria, a phenomenon known as atrial remodeling. Hypertension, heart failure, valvular heart disease, sleep apnea, congenital heart disease are well known risk factors for AF that contribute to the development of atrial substrate. There is some evidence that reversal of atrial remodeling is possible with correction of antecedent conditions, however the timing of the intervention or upstream therapy may be critical. This review will describe the pathophysiology of atrial remodeling as it pertains to AF. We will describe components of remodeling including changes in atrial refractoriness, conduction and atrial structure, in addition to autonomic changes and anatomic factors that predispose to remodeling. We will discuss our current understanding of the electrophysiological changes that contribute to AF persistence. We will describe nature of atrial and pulmonary vein remodeling in the context of different forms of AF, with and without predisposing risk factors. We will describe the nature of remodeling over time following therapeutic interventions such as AF ablation in order to show that it does not necessarily improve and may worsen. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22917748     DOI: 10.1016/j.pbiomolbio.2012.07.011

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  16 in total

Review 1.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

2.  Anatomy Versus Physiology-Guided Ablation for Persistent Atrial Fibrillation.

Authors:  Abhishek Deshmukh; Li Zhong; Joshua Slusser; Peilin Xiao; Pei Zhang; David Hodge; Mélèze Hocini; Christopher McLeod; David Bradley; Thomas Munger; Douglas Packer; Yong-Mei Cha
Journal:  J Atr Fibrillation       Date:  2020-04-30

Review 3.  [Atrial fibrillation and physical activity. An overview].

Authors:  R Laszlo; J M Steinacker
Journal:  Herz       Date:  2015-09-25       Impact factor: 1.443

4.  Device-Based Approaches to Modulate the Autonomic Nervous System and Cardiac Electrophysiology.

Authors:  William J Hucker; Jagmeet P Singh; Kimberly Parks; Antonis A Armoundas
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-05-30

5.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

6.  Conduction Disorders during Sinus Rhythm in Relation to Atrial Fibrillation Persistence.

Authors:  Willemijn F B van der Does; Annejet Heida; Lisette J M E van der Does; Ad J J C Bogers; Natasja M S de Groot
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

7.  Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation.

Authors:  Bianca C Bernardo; Geeta Sapra; Natalie L Patterson; Nelly Cemerlang; Helen Kiriazis; Tomomi Ueyama; Mark A Febbraio; Julie R McMullen
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

8.  Age, left atrial dimension and arterial stiffness after external cardioversion of atrial fibrillation. A vascular component in arrhythmia maintenance? Results from a preliminary study.

Authors:  Stefano Fumagalli; Debbie Gabbai; Besmir Nreu; Anna T Roberts; Serena Boni; Alice Ceccofiglio; Stefania Fracchia; Samuele Baldasseroni; Francesca Tarantini; Niccolò Marchionni
Journal:  Aging Clin Exp Res       Date:  2013-11-24       Impact factor: 3.636

9.  Pericardial fat is associated with atrial conduction: the Framingham Heart Study.

Authors:  Daniel J Friedman; Na Wang; James B Meigs; Udo Hoffmann; Joseph M Massaro; Caroline S Fox; Jared W Magnani
Journal:  J Am Heart Assoc       Date:  2014-03-04       Impact factor: 5.501

10.  Calpain-Calcineurin-Nuclear Factor Signaling and the Development of Atrial Fibrillation in Patients with Valvular Heart Disease and Diabetes.

Authors:  Yong Zhao; Guo-Ming Cui; Nan-Nan Zhou; Cong Li; Qing Zhang; Hui Sun; Bo Han; Cheng-Wei Zou; Li-Juan Wang; Xiao-Dong Li; Jian-Chun Wang
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.